Compare HUIZ & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HUIZ | CPIX |
|---|---|---|
| Founded | 2006 | 1999 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.5M | 34.1M |
| IPO Year | 2020 | 2009 |
| Metric | HUIZ | CPIX |
|---|---|---|
| Price | $3.21 | $4.12 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $2.30 | N/A |
| AVG Volume (30 Days) | 7.8K | ★ 220.6K |
| Earning Date | 03-24-2026 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.25 | N/A |
| Revenue | ★ $186,519,166.00 | $41,278,349.00 |
| Revenue This Year | $22.67 | N/A |
| Revenue Next Year | $8.55 | N/A |
| P/E Ratio | $12.65 | ★ N/A |
| Revenue Growth | ★ 19.12 | 12.21 |
| 52 Week Low | $1.50 | $1.85 |
| 52 Week High | $4.53 | $7.25 |
| Indicator | HUIZ | CPIX |
|---|---|---|
| Relative Strength Index (RSI) | 44.38 | 73.82 |
| Support Level | $3.04 | $3.93 |
| Resistance Level | $3.58 | $4.59 |
| Average True Range (ATR) | 0.28 | 0.42 |
| MACD | -0.02 | 0.16 |
| Stochastic Oscillator | 21.88 | 80.28 |
Huize Holding Ltd is an independent online insurance product and service platform in China. The company distributes on its platform insurance products underwritten by the insurance companies that cooperate with the company, which the company refers to as its insurer partners, and helps them reach a large number of insurance clients. The company's platform offers a digitalized insurance purchase experience and services through various internet and mobile internet channels. The company generates revenues from the insurance brokerage fees paid by its insurer partners.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.